The Top Data Challenge for Biopharma Launches: Accelerating Field Activation

Biopharmas are faced with many questions at launch that data helps answer. But even with the volume of data available today, about 34% of new product launches in the U.S. do not meet forecasts. Where are the gaps? A Veeva survey of 125 commercial and data leaders reveals challenges like speed to insight for the field and data integration are top of mind.

Why do over 33% of new product launches in the U.S. fail to meet forecasts?

The top challenge:
delivering insights to field teams quickly.

61%

of leaders say translating analytics into rapid field action is a top launch challenge

94%

of field teams don't receive daily alerts

What launch data challenges did you experience during your most recent launch?

Translating analytics into field action quickly

61%

Integrating disparate data sources and software

49%

Data latency/lack of real-time visibility

43%

Misalignment on KPIs/definition of success

43%

Lack of resources (forced to make tradeoffs)

37%

Skills gaps around generating insights from data

34%

Struggled to identify the right data sources

30%

No significant challenges

2%

Patient sees
HCP

Treatment/
diagnosis
of interest

Rapid
field alert

Slow, traditional alerts mean field teams can miss critical opportunities to influence care.

Traditional
field alert

within 24 hours

1–3 weeks

Daily insights for the field:

➜ Improve HCP outreach

➜ Optimize how field reps spend their time

➜ Help more patients start on therapies faster